Abstract Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Both the innate and adaptive immune systems contribute to the development of NAFLD. Patho-gen-associated molecular patterns and danger-associated molecular patterns are known to activate a variety of pat-tern-recognition receptors that result in inflammation. The key features of the immune system and inflammatory pathways in the development of NAFLD are discussed in this review
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major public health problem worldw...
Non-alcoholic steatohepatitis (NASH) is a disorder marked by alterations in hepatic lipid homeostasi...
Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic fatty live...
International audienceThe incidence of non-alcoholic fatty liver disease (NAFLD) has increased signi...
Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the metabolic syndrome and on...
In the past decade, nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic l...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Abstract: Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflam...
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Nonalcoholic fatty liver disease (NAFLD) is a disease spectrum that spans simple steatosis, fibrosis...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both...
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major public health problem worldw...
Non-alcoholic steatohepatitis (NASH) is a disorder marked by alterations in hepatic lipid homeostasi...
Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic fatty live...
International audienceThe incidence of non-alcoholic fatty liver disease (NAFLD) has increased signi...
Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the metabolic syndrome and on...
In the past decade, nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic l...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Abstract: Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflam...
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Nonalcoholic fatty liver disease (NAFLD) is a disease spectrum that spans simple steatosis, fibrosis...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both...
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major public health problem worldw...
Non-alcoholic steatohepatitis (NASH) is a disorder marked by alterations in hepatic lipid homeostasi...